NVO Novo Nordisk: $195 | The Cure since forever

senyor Updated   
NYSE:NVO   Novo Nordisk A/S
it addresses on major conditions of humans
Diabetes Cardio Alzheimer's

from acquisition to partnering and continuous r&d
this issue is a model to new science and tech companies making it to the next 50 years

key is innovation
opportunity is wait for major crash to upsize for OG investors
or simply appreciate the Business and Leadership behind the company.

if you get stuck at fresh highs
wait for 5 years to DCA in between the range

and sit for 12 years for that life changing gains..
every tiime CNBC covers a stock ... it dumps in a matter of days
trick is to wait when it bleeds..

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.